Can modulation of endothelial nitric oxide synthase explain the vasculoprotective actions of statins?
Statin-based drugs are the mainstay of therapy for coronary artery disease. Recent insights into the cellular mechanisms of this class of drugs suggest that modulation of nitric oxide synthesis contributes to their beneficial actions. These effects are independent of their lipid-lowering effects and result in enhanced nitric oxide release.
Related Questions
- Is the balance between nitric oxide and superoxide altered in spontaneously hypertensive rats with endothelial dysfunction?
- Does endothelial nitric oxide synthase gene variation play a role in the occurrence of hypertension in pregnancy?
- Does malarial tolerance, through nitric oxide, explain the low incidence of autoimmune disease in tropical Africa?
